Loading...

KYMR KYMERA THERAPEUTICS INC Earnings Reports 8-K Filing

KYMR

KYMR

KYMERA THERAPEUTICS INC

(KYMR)

2023 8-K

Bylaw Amendment

Sales Agreement Initiated

Financial Results Announcement

Stock Offering Details

FDA Trial Update

Clinical Trial Results

Financial Results Report

Management Change

Equity Offerings

Product Expansion

Investor Meetings

Product Expansion

Financial Results

Financial Update

Financial Results

Financial Results Announcement

Management Changes

Financial Results Announcement

Appointment of Director

Financial Results Announcement

Underwriting Agreement

Event Announcement

Expansion Plans

Clinical Trial Results

Financial Results Announcement

Financial Results Announcement

Annual Meeting of Shareholders

Appointment of Chief Operat...

Financial Results Announcement

Exposure to Closed Bank

Departure of Directors or C...

Financial Results Announcement

Financial Update

External Links:

Kymera Therapeutics, Inc. issued a press release announcing its preliminary cash balance of $560 million as of December 31, 2022 and provided a business update and outlook for 2023.

AI Assistant

KYMERA THERAPEUTICS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.